
| Name | Mitotic interactor and substrate of PLK1 | ||
| UniProt ID | MISP_HUMAN | ||
| Gene Name | MISP | ||
| Gene ID | 126353 | ||
| Synonyms |
MISP, C19orf21, MISP1
|
||
| Sequence |
MDRVTRYPILGIPQAHRGTGLVLDGDTSYTYHLVCMGPEASGWGQDEPQTWPTDHRAQQG
VQRQGVSYSVHAYTGQPSPRGLHSENREDEGWQVYRLGARDAHQGRPTWALRPEDGEDKE MKTYRLDAGDADPRRLCDLERERWAVIQGQAVRKSSTVATLQGTPDHGDPRTPGPPRSTP LEENVVDREQIDFLAARQQFLSLEQANKGAPHSSPARGTPAGTTPGASQAPKAFNKPHLA NGHVVPIKPQVKGVVREENKVRAVPTWASVQVVDDPGSLASVESPGTPKETPIEREIRLA QEREADLREQRGLRQATDHQELVEIPTRPLLTKLSLITAPRRERGRPSLYVQRDIVQETQ REEDHRREGLHVGRASTPDWVSEGPQPGLRRALSSDSILSPAPDARAADPAPEVRKVNRI PPDAYQPYLSPGTPQLEFSAFGAFGKPSSLSTAEAKAATSPKATMSPRHLSESSGKPLST KQEASKPPRGCPQANRGVVRWEYFRLRPLRFRAPDEPQQAQVPHVWGWEVAGAPALRLQK SQSSDLLERERESVLRREQEVAEERRNALFPEVFSPTPDENSDQNSRSSSQASGITGSYS VSESPFFSPIHLHSNVAWTVEDPVDSAPPGQRKKEQWYAGINPSDGINSEVLEAIRVTRH KNAMAERWESRIYASEEDD |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 1.A.14.3.14; 1.C.39.9.5; 8.A.67.1.4 | ||
| KEGG ID | hsa126353 | ||
| Pfam | PF15304 | ||
| Pair Name | Theaflavin 3,3'-digallate, Trastuzumab | |||
| Phytochemical | Theaflavin 3,3'-digallate | |||
| Drug | Trastuzumab | |||
| Disease Info | [ICD-11: 2B72.Z] | Gastric cancer | Investigative | |
| Regulate Info | Down-regulation | Mitotic interactor and substrate of PLK1 | Phosphorylation | |
| Result | These findings suggest an aberrant mitotic HER2-SHCBP1-PLK1 axis underlies trastuzumab sensitivity and offer a new strategy to combat gastric cancer. | |||